Cytek Biosciences, Inc. (CTKB)
NASDAQ · Healthcare
Cytek Biosciences, Inc. Gross Profit 2020–2025
Cytek Biosciences, Inc. annual/quarterly gross profit history and growth rate from 2020 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Cytek Biosciences, Inc. gross profit for the quarter ending March 31, 2026 was 21.3 M, a 5.44% increase year-over-year.
- Cytek Biosciences, Inc. gross profit for the twelve months ending March 31, 2026 was 92.8 M, a 11.28% decrease year-over-year.
- Cytek Biosciences, Inc. annual gross profit for 2025 was 104.5 M, a 5.98% decrease from 2024.
- Cytek Biosciences, Inc. annual gross profit for 2024 was 111.1 M, a 1.54% increase from 2023.
- Cytek Biosciences, Inc. annual gross profit for 2023 was 109.4 M, a 8.37% increase from 2022.
- Cytek Biosciences, Inc. annual gross profit for 2022 was 101.0 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cytek Biosciences, Inc. Gross Profit — FAQ
Cytek Biosciences, Inc. (CTKB) gross profit over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Cytek Biosciences, Inc.'s gross profit?
Cytek Biosciences, Inc. (CTKB) reported gross profit of $104M for fiscal 2025.
Where can I see CTKB's gross profit history?
The chart and table above show Cytek Biosciences, Inc.'s gross profit by year and by quarter, including the growth rate.